JPH0532656A - Decalin-based compound - Google Patents
Decalin-based compoundInfo
- Publication number
- JPH0532656A JPH0532656A JP3188595A JP18859591A JPH0532656A JP H0532656 A JPH0532656 A JP H0532656A JP 3188595 A JP3188595 A JP 3188595A JP 18859591 A JP18859591 A JP 18859591A JP H0532656 A JPH0532656 A JP H0532656A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- methanol
- compound
- chloroform
- ethyl acetate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 13
- NNBZCPXTIHJBJL-UHFFFAOYSA-N decalin Chemical compound C1CCCC2CCCCC21 NNBZCPXTIHJBJL-UHFFFAOYSA-N 0.000 title description 3
- PXXNTAGJWPJAGM-UHFFFAOYSA-N vertaline Natural products C1C2C=3C=C(OC)C(OC)=CC=3OC(C=C3)=CC=C3CCC(=O)OC1CC1N2CCCC1 PXXNTAGJWPJAGM-UHFFFAOYSA-N 0.000 title description 2
- 239000000126 substance Substances 0.000 claims abstract description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 33
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 abstract description 24
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 abstract description 20
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 9
- 238000012258 culturing Methods 0.000 abstract description 8
- 239000000843 powder Substances 0.000 abstract description 8
- 241000203233 Aspergillus versicolor Species 0.000 abstract description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 abstract description 6
- 239000007788 liquid Substances 0.000 abstract description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 abstract description 6
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 102000015336 Nerve Growth Factor Human genes 0.000 abstract description 5
- 108010025020 Nerve Growth Factor Proteins 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 abstract description 5
- 238000000921 elemental analysis Methods 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 238000006243 chemical reaction Methods 0.000 abstract description 3
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 abstract description 3
- 238000002844 melting Methods 0.000 abstract description 3
- 230000008018 melting Effects 0.000 abstract description 3
- 244000099147 Ananas comosus Species 0.000 abstract description 2
- 235000007119 Ananas comosus Nutrition 0.000 abstract description 2
- 229940053128 nerve growth factor Drugs 0.000 abstract description 2
- HORQAOAYAYGIBM-UHFFFAOYSA-N 2,4-dinitrophenylhydrazine Chemical compound NNC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O HORQAOAYAYGIBM-UHFFFAOYSA-N 0.000 abstract 1
- 230000002205 anti-dementic effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- JYVHOGDBFNJNMR-UHFFFAOYSA-N hexane;hydrate Chemical compound O.CCCCCC JYVHOGDBFNJNMR-UHFFFAOYSA-N 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 23
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 8
- 238000000862 absorption spectrum Methods 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 5
- 241000228212 Aspergillus Species 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 239000006188 syrup Substances 0.000 description 4
- 235000020357 syrup Nutrition 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002523 gelfiltration Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002143 fast-atom bombardment mass spectrum Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000006877 oatmeal agar Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 108010023063 Bacto-peptone Proteins 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940005524 anti-dementia drug Drugs 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- LKQHBDDYJHFMGE-UHFFFAOYSA-N chloroform N,N-diethylethanamine methanol hydrate Chemical compound O.OC.ClC(Cl)Cl.CCN(CC)CC LKQHBDDYJHFMGE-UHFFFAOYSA-N 0.000 description 1
- 230000001713 cholinergic effect Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- -1 decalin compound Chemical class 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000003810 ethyl acetate extraction Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000014537 nerve growth factor production Effects 0.000 description 1
- 239000002664 nootropic agent Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 210000004129 prosencephalon Anatomy 0.000 description 1
- 102220201851 rs143406017 Human genes 0.000 description 1
- 150000003377 silicon compounds Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は神経成長因子(以下、N
GFと称する。)の産生促進効果を有するデカリン系化
合物に関する。The present invention relates to nerve growth factor (hereinafter referred to as N
It is called GF. The present invention relates to a decalin compound having an effect of promoting production.
【0002】[0002]
【従来の技術】本発明の化合物に構造類似で、かつ同様
の作用を有する化合物は知られていない。2. Description of the Related Art There are no known compounds that are structurally similar to the compounds of the present invention and have similar effects.
【0003】[0003]
【発明が解決しようとする課題】本発明の目的は、NG
Fの産生促進効果を有する新規な化合物を提供すること
にある。DISCLOSURE OF THE INVENTION The object of the present invention is NG
It is intended to provide a novel compound having an F production promoting effect.
【0004】[0004]
【課題を解決するための手段】本発明者らは、前記目的
の達成のために多数の菌株を土壌より分離し、その菌株
の代謝産物について種々検討した結果、ある種の菌株
が、NGF産生促進効果を有する新規な生理活性物質を
生産することを見いだし本発明を完成するに至った。す
なわち、本発明は、式[Means for Solving the Problems] The present inventors have isolated a large number of strains from the soil in order to achieve the above-mentioned object, and variously studied the metabolites of the strains. As a result, a certain strain produced NGF. The inventors have found that a novel physiologically active substance having a promoting effect is produced and completed the present invention. That is, the present invention is
【0005】[0005]
【化4】 [Chemical 4]
【0006】(化4中、Rは式(Where R is an expression
【0007】[0007]
【化5】 [Chemical 5]
【0008】で表される基または式A group or formula represented by
【0009】[0009]
【化6】 [Chemical 6]
【0010】で表される基を示す。)で表される化合物
[以下、Rが化5で表される基の化合物をNG−111
と、Rが化6で表される基の化合物をNG−112と称
する。]である。NG−111及びNG−112を生産
する微生物は、本発明者らが沖縄県金武町郊外にて採取
したパイナップル落葉から新たに分離した菌株であり、
微生物の名称「Aspergillus versicolor F-5015」及び
微生物寄託番号「微工研菌寄第12361号(FERM P-1
2361)」として、工業技術院微生物工業技術研究所に寄
託されている。A group represented by A compound represented by the formula [hereinafter, R is a compound represented by the formula 5
And a compound in which R is a group represented by Chemical formula 6 is referred to as NG-112. ]. The microorganisms producing NG-111 and NG-112 are strains newly isolated from pineapple litter leaves collected by the present inventors in the suburbs of Kin-cho, Okinawa Prefecture,
The name of the microorganism is " Aspergillus versicolor F-5015" and the microorganism deposit number is "Microtech Lab. No. 12361 (FERM P-1
2361) ”has been deposited with the Institute of Microbial Technology, Institute of Industrial Technology.
【0011】この菌株の菌学的性状を以下に示す。 [形態]本菌株は、バレイショ・ブドウ糖寒天培地、オ
−トミ−ル寒天培地で良好に生育し、胞子の形成はバレ
イショ・ブドウ糖寒天培地で良好、オートミール寒天培
地、麦芽エキス寒天培地、YpSs寒天培地では中程度
である。本菌株がツァペック・酵母エキス寒天培地上、
25℃、7日間の培養で形成したコロニ−を光学顕微鏡
で観察すると、菌糸は隔壁を有し高度に分枝しており、
基底菌糸から長く伸長した分生子柄の先端が球状に膨ら
み、Aspergillus属に特徴的な復列、放射状の分生子頭
が観察される。また同時に気生菌糸から直接あるいは短
い分生子柄を介して先端に、1〜7個のフィアライドを
輪生したペニシリ様の形態も多数認められる。分生子頭
を形成する場合の分生子柄は無色で壁が厚く、表面は滑
面、大きさは153〜388μm×3.0〜6.5μm
である。頂のうは球形からやや亜球形で大きさはφ6.
5μm〜15.0μmである。メトレの大きさは4.0
〜7.0μm×3.0〜3.5μmである。フィアライ
ドの大きさは4.5〜8.0μm×2.0〜3.0μm
である。分生子は球形で隔壁はなく、形成直後は白色、
やがて灰緑色となり、表面はとげ状、大きさはφ2.8
〜4.0μmである。一方、ペニシリ様の形態を形成す
る場合の分生子柄は0〜15.0μm×1.0〜2.0
μmで、先端部分が頂のう様にわずかに膨潤しているも
のが多く認められる。フィアライド及び分生子の形態は
分生子頭形成時に一致している。なお、培養を3週間に
延長したが、子のう果の形成は認められなかった。 [培地上での諸性状]各種培地上で、26℃,14日間
培養したときの肉眼による観察結果を表1に示した。な
お、色の表示は日本規格協会、「JIS色名帳」(19
85年)の系統色名を引用した。The bacteriological properties of this strain are shown below. [Morphology] This strain grows well on potato / glucose agar medium and oatmeal agar medium, and spore formation is good on potato / glucose agar medium, oatmeal agar medium, malt extract agar medium, YpSs agar medium. Then it is moderate. This strain is on Czapek / Yeast extract agar medium,
When the colony formed by culturing at 25 ° C. for 7 days is observed with an optical microscope, the mycelium has a septum and is highly branched,
The conidia stalks elongated from the basal hyphae swell in a spherical shape, and radial conidia heads are observed, which are characteristic of Aspergillus spp. At the same time, a large number of penicillate-like morphology in which 1 to 7 phialides are circulated from the aerial hyphae directly or through the short conidia stalk is also recognized. When the conidia head is formed, the conidia stalk is colorless and has a thick wall, the surface is smooth, and the size is 153 to 388 μm × 3.0 to 6.5 μm.
Is. The apex is spherical to slightly subspherical with a size of φ6.
It is 5 μm to 15.0 μm. The size of the metre is 4.0
˜7.0 μm × 3.0 to 3.5 μm. The size of the phialide is 4.5-8.0 μm × 2.0-3.0 μm
Is. Conidia are spherical and have no septum, white immediately after formation,
Eventually it became grayish green, the surface was thorny, and the size was φ2.8.
Is about 4.0 μm. On the other hand, the conidia peduncle when forming a penicilli-like morphology is 0 to 15.0 μm × 1.0 to 2.0.
In many cases, the tip portion is slightly swollen like a crest at μm. The morphology of phialides and conidia is consistent during conidial head formation. Although the culture was extended to 3 weeks, the formation of ascaris was not observed. [Various Properties on Medium] Table 1 shows the results of visual observation when cultured at 26 ° C. for 14 days on various mediums. The colors are displayed by the Japanese Standards Association, "JIS Color Name Book" (19
1985) systematic color names are quoted.
【0012】[0012]
【表1】 [Table 1]
【0013】[生理的性質] 1)生育pH範囲及び最適pH 本菌株はYpSs液体培地において、pH3〜10の範
囲で生育し、最適pHは5〜6である。 2)生育温度範囲及び最適温度 本菌株はサブロ−液体培地において、13〜33℃の範
囲で生育し、最適温度は24〜27℃である。 3)好気性,嫌気性の区別;好気性 以上の形態的特徴及び培養上の性状から、本菌株が不完
全菌亜門、Aspergillus属の1菌種であることが明かで
あり、宇田川 俊一,椿啓介編「菌類図鑑」(1978
年)、K.B.Raper,D.I.Fennell著「THE GENUS
Aspergillus 」(1965年)及びM.A.Klich,
J.I.Pitt著「ALABORATORY GUIDETO COMMON Asperg
illus SPECIES AND THEIR TELEOMORPHS」(1988
年)に報告されている多くの既知菌株と比較検討した。
その結果、本菌株はAspergillus versicolor(Vuill.)
Tiraboschi に最も近い性状を示すことが明かとなり、
本菌株を「Aspergillus versicolor F-5015」と命名し
た。[Physiological Properties] 1) Growth pH Range and Optimum pH This strain grows in YpSs liquid medium in a pH range of 3 to 10, and the optimum pH is 5 to 6. 2) Growth temperature range and optimum temperature This strain grows in a Sabro-liquid medium in the range of 13 to 33 ° C, and the optimum temperature is 24 to 27 ° C. 3) Distinction between aerobic and anaerobic; aerobic From the above morphological characteristics and culturing characteristics, it is clear that this strain is a subspecies of Aspergillus spp. Keisuke Tsubaki's "Fungus Encyclopedia" (1978
Year), K. B. Raper, D.M. I. Fennell "THE GENUS
Aspergillus "(1965) and M.G. A. Klich,
J. I. Pitt's `` ALABORATORY GUIDE TO COMMON Asperg
illus SPECIES AND THEIR TELEO MORPHS "(1988
Year)) and compared with many known strains.
As a result, this strain was Aspergillus versicolor (Vuill.)
It became clear that it shows the properties closest to Tiraboschi,
This strain was named " Aspergillus versicolor F-5015".
【0014】NG−111及びNG−112の生産は、
大略一般の発酵生成物を生産する場合に準じ、各種の栄
養物質を含む培地で Aspergillus versicolor F-5015を
好気的条件下で培養することにより行う。培地は主とし
て液体培地を用い、炭素源、窒素源、無機塩よりなり、
必要に応じてビタミン類、先駆物質、消泡剤を加えるこ
とができ、pHは6前後に調整する。炭素源としては、
例えばグルコース、マルトース、デキストリン、グリセ
リン、澱粉などを単独かまたは混合して用いる。窒素源
としては、例えば酵母エキス、ペプトン、肉エキス、大
豆粉、コーン・スティー・リカー、尿素、アンモニウム
塩などを単独かまたは混合して用いる。無機塩として
は、例えば燐酸一カリウム、硫酸マグネシウム、塩化ナ
トリウム、炭酸カルシウムなどを単独かまたは混合して
用いる。消泡剤としてはアデカノール、シリコン化合物
などを用いることができる。The production of NG-111 and NG-112 is
According to the case of producing a general fermented product, Aspergillus versicolor F-5015 is cultured under aerobic conditions in a medium containing various nutrients. The liquid medium is mainly a liquid medium, consisting of carbon source, nitrogen source, and inorganic salt,
If necessary, vitamins, precursors and defoamers can be added, and the pH is adjusted to around 6. As a carbon source,
For example, glucose, maltose, dextrin, glycerin, starch and the like are used alone or in combination. As the nitrogen source, for example, yeast extract, peptone, meat extract, soybean powder, corn steep liquor, urea, ammonium salt, etc. may be used alone or in combination. As the inorganic salt, for example, monopotassium phosphate, magnesium sulfate, sodium chloride, calcium carbonate, etc. may be used alone or in combination. As the defoaming agent, adecanol, a silicon compound or the like can be used.
【0015】培養方法としては振盪培養、通気撹拌培養
などの好気的培養が適しており、pH3〜10、25〜
28℃で2〜3日間、望ましくはpH4〜6、26〜2
7℃で3日間培養する。この培養により生産されたNG
−111及びNG−112を単離するには、発酵生産物
を採取する一般的な方法に準じて行えばよい。すなわ
ち、培養終了後、遠心分離または濾過により培養濾液と
菌体に分離した後、濾液を酢酸エチルエステルなどの非
水溶性有機溶媒で抽出し、これを減圧濃縮してシロップ
状とする。このシロップを再度酢酸エチルエステル、ベ
ンゼン、クロロホルム、アセトン、メタノールなどの有
機溶媒に溶解し、シリカゲルを用いたカラムクロマトグ
ラフィー、ゲル濾過カラムクロマトグラフィー及び薄層
クロマトグラフィーに付することによりNG−111及
びNG−112を精製、単離することができる。As the culturing method, aerobic culturing such as shaking culturing, aeration stirring culturing and the like is suitable, and the pH is 3 to 10, 25 to 25.
28 ° C for 2-3 days, preferably pH 4-6, 26-2
Incubate at 7 ° C for 3 days. NG produced by this culture
In order to isolate -111 and NG-112, it may be carried out according to a general method for collecting a fermentation product. That is, after the completion of the culture, the culture filtrate and the bacterial cells are separated by centrifugation or filtration, and the filtrate is extracted with a non-water-soluble organic solvent such as ethyl acetate, and concentrated under reduced pressure to form a syrup. The syrup was again dissolved in an organic solvent such as ethyl acetate, benzene, chloroform, acetone, and methanol, and subjected to column chromatography using silica gel, gel filtration column chromatography, and thin layer chromatography to obtain NG-111 and NG-112 can be purified and isolated.
【0016】以上の方法によって得られた本発明の目的
物質であるNG−111及びNG−112は、その元素
分析値、分子量、紫外線吸収スペクトル、1H−NMR
スペクトル、13C−NMRスペクトル等の解析結果より
化4のように構造式が決定された。NG−111及びN
G−112の理化学的性質は以下の通りである。NG-111 and NG-112, which are the target substances of the present invention obtained by the above-mentioned method, have their elemental analysis values, molecular weights, ultraviolet absorption spectra and 1 H-NMR.
The structural formula was determined as shown in Chemical formula 4 from the analysis results of the spectrum, 13 C-NMR spectrum and the like. NG-111 and N
The physicochemical properties of G-112 are as follows.
【0017】NG−111 (a)元素分析値: 実測値(%) C 68.07,H 7.51 理論値(%) C 68.87,H 7.46 (C31H40O8として計算) (b)FABマススペクトル: FAB(+) m/z 563(M+Na)+ FAB(−) m/z 539(M−H)- (c)分子量:540 (d)融点:135〜138℃ (e)比旋光度: [α]D 25=75.0°(c=1.0,メタノール) (f)紫外線吸収スペクトル: λmax 196nm(ε=11000) 240nm(ε=20600) 328nm(ε=15600) (メタノール溶液中で測定) (g)赤外線吸収スペクトル:臭化カリウム錠中で測定
した結果を図1に示す。 (h)1H−NMRスペクトル:重ジメチルスルフォキ
シド中、400MHzで測定した結果を図2に示す。 (i)13C−NMRスペクトル:重ジメチルスルフォキ
シド中、100MHzで測定した結果を図3に示す。 (j)溶剤に対する溶解性: 易溶;メタノール、エタノール、ジメチルスルフォキシ
ド 難溶;アセトン、クロロホルム、酢酸エチルエステル 不溶;水,n−ヘキサン (k)呈色反応; 陽性:ヨウ素、硫酸、2,4−ジニトロフェニルヒドラ
ジン 陰性:ニンヒドリン (l)塩基性、酸性、中性の区別:酸性 (m)物質の色:黄色粉末NG-111 (a) Elemental analysis value: measured value (%) C 68.07, H 7.51 theoretical value (%) C 68.87, H 7.46 (C31H40O8(B) FAB mass spectrum: FAB (+) m / z 563 (M + Na)+ FAB (-) m / z 539 (M-H)- (C) Molecular weight: 540 (d) Melting point: 135-138 ° C (e) Specific optical rotation: [α]D twenty five= 75.0 ° (c = 1.0, methanol) (f) Ultraviolet absorption spectrum: λmax 196 nm (ε = 11000) 240 nm (ε = 20600) 328 nm (ε = 15600) (measured in methanol solution) (g) Infrared absorption spectrum: measured in potassium bromide tablets
The results obtained are shown in FIG. (H)1H-NMR spectrum: heavy dimethyl sulfoxide
The result measured at 400 MHz in SID is shown in FIG. (I)13C-NMR spectrum: heavy dimethyl sulfoxide
The result measured at 100 MHz in SID is shown in FIG. (J) Solubility in solvent: Easily soluble; methanol, ethanol, dimethylsulfoxy
Insoluble; acetone, chloroform, ethyl acetate insoluble; water, n-hexane (k) color reaction; positive: iodine, sulfuric acid, 2,4-dinitrophenylhydra
Zin Negative: Ninhydrin (l) Distinction between basic, acidic and neutral: Acidic (m) Color of substance: Yellow powder
【0018】NG−112 (a)元素分析値: 実測値(%) C 68.43,H 7.92 理論値(%) C 68.61,H 7.80 (C31H42O8として計算) (b)FABマススペクトル: FAB(+) m/z 565(M+Na)+ FAB(−) m/z 541(M−H)- (c)分子量:542 (d)融点:136〜140℃ (e)比旋光度: [α]D 25=60.2°(c=0.47,メタノール) (f)紫外線吸収スペクトル: λmax 205nm(ε= 7590) 231nm(ε=10800) 339nm(ε=79700) (メタノール溶液中で測定) (g)赤外線吸収スペクトル:臭化カリウム錠中で測定
した結果を図4に示す。 (h)1H−NMRスペクトル:重ジメチルスルフォキ
シド中、400MHzで測定した結果を図5に示す。 (i)13C−NMRスペクトル:重ジメチルスルフォキ
シド中、100MHzで測定した結果を図6に示す。 (j)溶剤に対する溶解性: 易溶;メタノール、エタノール、ジメチルスルフォキシ
ド 難溶;アセトン、クロロホルム、酢酸エチルエステル 不溶;水,n−ヘキサン (k)呈色反応; 陽性:ヨウ素、硫酸、2,4−ジニトロフェニルヒドラ
ジン 陰性:ニンヒドリン (l)塩基性、酸性、中性の区別:酸性 (m)物質の色:黄色粉末NG-112 (a) Elemental analysis value: measured value (%) C 68.43, H 7.92 theoretical value (%) C 68.61, H 7.80 (C31H42O8(B) FAB mass spectrum: FAB (+) m / z 565 (M + Na)+ FAB (-) m / z 541 (MH)- (C) Molecular weight: 542 (d) Melting point: 136 to 140 ° C. (e) Specific optical rotation: [α]D twenty five= 60.2 ° (c = 0.47, methanol) (f) Ultraviolet absorption spectrum: λmax 205 nm (ε = 7590) 231 nm (ε = 10800) 339 nm (ε = 79700) (measured in methanol solution) (g) Infrared absorption spectrum: measured in potassium bromide tablets
The results obtained are shown in FIG. (H)1H-NMR spectrum: heavy dimethyl sulfoxide
The result of measurement at 400 MHz in SID is shown in FIG. (I)13C-NMR spectrum: heavy dimethyl sulfoxide
The result of measurement at 100 MHz in SID is shown in FIG. (J) Solubility in solvent: Easily soluble; methanol, ethanol, dimethylsulfoxy
Insoluble; acetone, chloroform, ethyl acetate insoluble; water, n-hexane (k) color reaction; positive: iodine, sulfuric acid, 2,4-dinitrophenylhydra
Zin Negative: Ninhydrin (l) Distinction between basic, acidic and neutral: Acidic (m) Color of substance: Yellow powder
【0019】[0019]
【発明の効果】近年増えつつあるアルツハイマー型痴呆
症は、前脳基底野のコリン作動性神経細胞が選択的に脱
落するために起こるといわれている。NGFは、この神
経細胞の脱落を抑制する作用があることから、その産生
促進効果を有する本発明の化合物は、抗痴呆薬として有
用である。The Alzheimer-type dementia, which is increasing in number in recent years, is said to occur because the cholinergic nerve cells in the basal forebrain are selectively lost. Since NGF has an action of suppressing the loss of nerve cells, the compound of the present invention having a production promoting effect is useful as an anti-dementia drug.
【0020】[0020]
【実施例】以下、実施例及び試験例を示し、本発明を更
に詳細に説明する。 実施例 100ml当りグルコース2g、ポリペプトン0.5
g、酵母エキス0.3g、リン酸一カリウム0.1g、
硫酸マグネシウム0.05gからなるpH6の無菌液体
培地にAspergillus versicolor F-5015株を接種し、2
6℃、72時間振盪培養した。次に5L容培養ミニジャ
ーを用いて、種培養と同じ組成の無菌培地3Lに前記種
培養液100mlを接種し26℃、72時間撹拌通気培
養した。培養終了後遠心分離機で上澄液と菌体に分け
た。得られた上澄液を等量の酢酸エチルエステルで2回
抽出し、酢酸エチルエステル抽出区分を合わせ無水硫酸
ナトリウムで脱水後、減圧濃縮乾固し黄色シロップ45
gを得た。EXAMPLES Hereinafter, the present invention will be described in more detail by showing Examples and Test Examples. Example 2 g of glucose per 100 ml, 0.5 of polypeptone
g, yeast extract 0.3 g, monopotassium phosphate 0.1 g,
Aspergillus versicolor F-5015 strain was inoculated into a sterile liquid medium of pH 6 containing 0.05 g of magnesium sulfate, and 2
Culture was carried out at 6 ° C. for 72 hours with shaking. Next, using a 5 L culture mini jar, 100 ml of the seed culture solution was inoculated into 3 L of sterile medium having the same composition as the seed culture, and agitated and aerated for 72 hours at 26 ° C. After completion of the culture, the supernatant and the cells were separated with a centrifuge. The resulting supernatant was extracted twice with an equal amount of ethyl acetate, the ethyl acetate extraction sections were combined, dehydrated with anhydrous sodium sulfate, and concentrated to dryness under reduced pressure to give a yellow syrup 45.
g was obtained.
【0021】この黄色シロップをクロロホルム20ml
に溶解し、クロロホルムで調製したシリカゲル[キーゼ
ルゲル(商品名;メルク社製)]の250mlカラムに
吸着させた。クロロホルム500mlで洗浄後、クロロ
ホルム−メタノール(90:10),クロロホルム−メ
タノール(95:15),クロロホルム−メタノール
(80:20)の混合溶媒各500mlで活性画分を溶
出した。この活性画分を集め減圧濃縮乾固し、NG−1
11及び112の粗粉末10gを得た。シリカゲルカラ
ム精製で得られたNG−111及びNG−112の粗粉
末をメタノール8mlに溶解した。この溶液をメタノー
ルで調製した、セファデックスLH−20(商品名;フ
ァルマシア社製)に付し、ゲル濾過し、活性区分を集め
て濃縮し、粗粉末4.5gを得た。20 ml of this yellow syrup is chloroform
And was adsorbed to a 250 ml column of silica gel [Kieselgel (trade name; manufactured by Merck)] prepared with chloroform. After washing with 500 ml of chloroform, the active fraction was eluted with 500 ml each of a mixed solvent of chloroform-methanol (90:10), chloroform-methanol (95:15) and chloroform-methanol (80:20). The active fractions were collected and concentrated under reduced pressure to dryness, and NG-1
10 g of crude powder of 11 and 112 was obtained. Crude powders of NG-111 and NG-112 obtained by silica gel column purification were dissolved in 8 ml of methanol. This solution was applied to Sephadex LH-20 (trade name; manufactured by Pharmacia) prepared with methanol, subjected to gel filtration, and the active fractions were collected and concentrated to obtain 4.5 g of a coarse powder.
【0022】このゲル濾過カラム精製で得られた粗粉末
4.5gをシリカゲルプレート[キーゼルゲル60F
20cm×20cm×0.5mm(商品名;メルク社
製)]を用い、クロロホルム−メタノール−水−トリエ
チルアミン(70:30:5:0.1)の溶媒系で展開
した。Rf値0.66と0.61の活性画分をかきと
り、それぞれに100mlの水と100mlの酢酸エチ
ルエステルを加えて抽出した。酢酸エチルエステル層を
無水硫酸ナトリウムで脱水後、濃縮乾固し、NG−11
1(Rf値0.66)を400mg,NG−112(R
f値0.61)を71mg得た。4.5 g of the crude powder obtained by this gel filtration column purification was added to a silica gel plate [Kieselgel 60F].
20 cm × 20 cm × 0.5 mm (trade name; manufactured by Merck & Co., Inc.)] and developed in a solvent system of chloroform-methanol-water-triethylamine (70: 30: 5: 0.1). The active fractions having Rf values of 0.66 and 0.61 were scraped off, and 100 ml of water and 100 ml of ethyl acetate were added to each of the fractions for extraction. The ethyl acetate layer was dehydrated with anhydrous sodium sulfate and then concentrated to dryness, and NG-11
1 (Rf value 0.66) 400 mg, NG-112 (R
71 mg of f value 0.61) was obtained.
【0023】試験例 [NGF産生促進効果試験] (検体)実施例で得られたNG−111及びNG−11
2をそれぞれジメチルスルフォキシドに溶解し、これを
後記培地中に混ぜて200倍に希釈し、NG−111ま
たはNG−112を0.003μg/ml〜0.1μg
/mlの濃度となるように検体を含有する培地を調製し
た。 (試験細胞) L−M細胞(マウス線維芽細胞) (使用した培地)0.5%バクトペプトン、50ユニッ
ト/mlペニシリン、50μg/mlストレプトマイシ
ンを含有する199培地(ギブコ社製) (試験方法)L−M細胞を前記培地にて前培養し、24
孔プレート(コーニング社製,培養孔あたりの面積2c
m2)に約7×104個/培養孔の細胞を播き、37℃,
5%CO2で3日間培養し、コンフレントとした。次い
で、培地を各種濃度の検体を含有する培地と交換した。
24時間培養後、培地中のNGF濃度を酵素免疫測定法
[S.Furukawaら,J.Neurochem,第40巻,第73
4〜744ページ(1984年)]によって測定した。
活性はコントロールを100%として示した。Test Example [NGF production promoting effect test] (Sample) NG-111 and NG-11 obtained in the examples
2 were each dissolved in dimethylsulfoxide, and this was mixed in the medium described below and diluted 200-fold, and NG-111 or NG-112 was added at 0.003 μg / ml to 0.1 μg.
The medium containing the sample was prepared so as to have a concentration of / ml. (Test cells) LM cells (mouse fibroblasts) (Used medium) 199 medium (manufactured by Gibco) containing 0.5% bactopeptone, 50 units / ml penicillin, and 50 μg / ml streptomycin (test method) LM cells were pre-cultured in the above medium, 24
Pore plate (Corning, area 2c per culture hole)
m 2 ), seed about 7 × 10 4 cells / culture hole, and incubate at 37 ° C.
The cells were cultured in 5% CO 2 for 3 days to be confluent. The medium was then replaced with medium containing various concentrations of analyte.
After culturing for 24 hours, the NGF concentration in the medium was measured by enzyme immunoassay [S. Furukawa et al. Neurochem, Volume 40, Volume 73
4 to 744 (1984)].
The activity was shown with the control being 100%.
【0024】[0024]
【数1】 [Equation 1]
【0025】(結果)結果を表2に示す。(Results) The results are shown in Table 2.
【0026】[0026]
【表2】 [Table 2]
【図1】臭化カリウム錠中で測定したNG−111の赤
外線吸収スペクトルを示す。FIG. 1 shows an infrared absorption spectrum of NG-111 measured in a potassium bromide tablet.
【図2】重ジメチルスルフォキシド中、400MHzで
測定したNG−111の1H−NMRスペクトルを示
す。FIG. 2 shows the 1 H-NMR spectrum of NG-111 measured at 400 MHz in heavy dimethyl sulfoxide.
【図3】重ジメチルスルフォキシド中、100MHzで
測定したNG−111の13C−NMRスペクトルを示
す。FIG. 3 shows the 13 C-NMR spectrum of NG-111 measured at 100 MHz in heavy dimethyl sulfoxide.
【図4】臭化カリウム錠中で測定したNG−112の赤
外線吸収スペクトルを示す。FIG. 4 shows an infrared absorption spectrum of NG-112 measured in a potassium bromide tablet.
【図5】重ジメチルスルフォキシド中、400MHzで
測定したNG−112の1H−NMRスペクトルを示
す。FIG. 5 shows the 1 H-NMR spectrum of NG-112 measured at 400 MHz in heavy dimethyl sulfoxide.
【図6】重ジメチルスルフォキシド中、100MHzで
測定したNG−112の13C−NMRスペクトルを示
す。FIG. 6 shows the 13 C-NMR spectrum of NG-112 measured at 100 MHz in heavy dimethyl sulfoxide.
フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 C12R 1:66) 7804−4B (72)発明者 伊藤 まゆみ 東京都豊島区高田3丁目24番1号 大正製 薬株式会社内 (72)発明者 花田 和紀 東京都豊島区高田3丁目24番1号 大正製 薬株式会社内Continuation of the front page (51) Int.Cl. 5 Identification number Office reference number FI technical display location C12R 1:66) 7804-4B (72) Inventor Mayumi Ito 3-24-1 Takada, Toshima-ku, Tokyo Taisho product (72) Inventor Kazuki Hanada 3-24-1 Takada, Toshima-ku, Tokyo Taisho Seiyaku Co., Ltd.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3188595A JPH0532656A (en) | 1991-07-29 | 1991-07-29 | Decalin-based compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3188595A JPH0532656A (en) | 1991-07-29 | 1991-07-29 | Decalin-based compound |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0532656A true JPH0532656A (en) | 1993-02-09 |
Family
ID=16226411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3188595A Pending JPH0532656A (en) | 1991-07-29 | 1991-07-29 | Decalin-based compound |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0532656A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3335764A1 (en) * | 2016-12-19 | 2018-06-20 | Infinitec Activos S.L. | A strain of aspergillus versicolor and applications thereof |
EP3336173A1 (en) * | 2016-12-19 | 2018-06-20 | Infinitec Activos S.L. | A strain of aspergillus versicolor and applications thereof |
-
1991
- 1991-07-29 JP JP3188595A patent/JPH0532656A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3335764A1 (en) * | 2016-12-19 | 2018-06-20 | Infinitec Activos S.L. | A strain of aspergillus versicolor and applications thereof |
EP3336173A1 (en) * | 2016-12-19 | 2018-06-20 | Infinitec Activos S.L. | A strain of aspergillus versicolor and applications thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IE49743B1 (en) | Antihypercholesteraemic agent,monacolin k,and its preparation | |
JP3854866B2 (en) | Method for producing mycophenolic acid and derivatives thereof | |
JPH0532656A (en) | Decalin-based compound | |
KR100186758B1 (en) | Process for preparing pravastatin precursor | |
JP3026864B2 (en) | New sesquiterpene derivatives | |
JP3145200B2 (en) | New isochroman carboxylic acid derivatives | |
JPH0748397A (en) | Steroidal compound | |
US3775433A (en) | Antimicrobial metabolite s491beta and s491ypsilon and chemical derivatives | |
JPH03227971A (en) | Carbazole compound | |
JP2844854B2 (en) | FR901308 substance and method for producing the same | |
JPS6015318B2 (en) | New antibiotic SF-1942 substance, its manufacturing method and anticancer agent containing it | |
JPH05176782A (en) | Ngf activity-enhancing factor | |
JPH05255184A (en) | New compound ilicicolinic acid a or b | |
JP3067904B2 (en) | A new penicillium mold | |
JPS6265685A (en) | Physiologically active substance fd-838 and production thereof | |
JPH06172378A (en) | Steroid compound | |
JPH06239869A (en) | Ngf action enhancer | |
JPH083097A (en) | Benzophenone-based compound fd-549 | |
JPH0592967A (en) | Novel natural substance with 10-membered ring lactone structure | |
JPH0341089A (en) | Physiologically active substance 3127 | |
JPH0429995A (en) | New antibiotic substance wf3010 and its production | |
JPH04321698A (en) | Physiologically active substance m6124 and production thereof | |
JPH06271561A (en) | Dibenzoxepin-based compound | |
JPH0770101A (en) | Unsaturated lactone compound | |
JP2002518515A (en) | Compound WF002, its preparation and its use |